AstraZeneca (AZN.US) monoclonal antibody new drug approved for two indications in China
智通财经2026/08/18 07:56Show original
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!
A welcome pack worth 6200 USDT for new users! Sign up now!
```htmlAccording to Zhihui Finance APP, on August 17, AstraZeneca (AZN.US) announced the official launch of Tezepelumab injection in China. Tezepelumab is a biologic used to treat severe asthma, overcoming phenotype and biomarker level limitations, and targets thymic stromal lymphopoietin (TSLP).```
0
0
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now！
You may also like
Crypto prices
More
Bitcoin
BTC
$76,690.39
-0.80%
Ethereum
ETH
$2,475.12
-2.32%
Tether USDt
USDT
$0.9996
-0.01%
BNB
BNB
$715.49
-2.89%
XRP
XRP
$1.34
-2.38%
USDC
USDC
$0.9998
-0.01%
Solana
SOL
$99.6
-2.62%
TRON
TRX
$0.3406
-0.12%
Hyperliquid
HYPE
$77.4
-3.62%
Zcash
ZEC
$1,090.57
-5.88%
How to buy BTC
Bitget lists BTC – Buy or sell BTC quickly on Bitget!
Trade now
Become a trader now?A welcome pack worth 6200 USDT for new users!
Sign up now